BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33448852
Number of visits today
5040
Number of downloads
16634015
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Jain S, Maque J, Galoosian A, Osuna-Garcia A, May FP. Optimal Strategies for Colorectal Cancer Screening. Curr Treat Options Oncol 2022. [PMID: 35316477 DOI: 10.1007/s11864-022-00962-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ploukou S, Birtsou C, Gavana M, Tsakiridou K, Dandoulakis M, Symintiridou D, Moraiti E, Parisis A, Smyrnakis E. General Practitioners’ attitudes and beliefs on barriers to colorectal cancer screening: A qualitative study. Popul Med 2023;5:1-8. [DOI: 10.18332/popmed/161128] [Reference Citation Analysis]
2 Yang S, Zhao J, Liu Q. Occult colon cancer with liver abscess and pancreatitis as the first manifestations: A case report. Medicine (Baltimore) 2023;102:e32654. [PMID: 36701699 DOI: 10.1097/MD.0000000000032654] [Reference Citation Analysis]
3 Sun X, Fan J, Zhao W, Lu Q, Gu J, Lv L, Gao H, Ye G. Screening intention of MTs-DNA test for Colorectal Cancer screening and associated factors among hospital-based populations in southeastern China.. [DOI: 10.21203/rs.3.rs-2062691/v1] [Reference Citation Analysis]
4 Severskaya NV, Nevolskikh AA, Avdeenko VA, Hailova ZV, Ivanov SA. Fecal occult blood testing in colorectal cancer screening programs. Issled prakt med (Print) 2022;9:145-159. [DOI: 10.17709/2410-1893-2022-9-3-11] [Reference Citation Analysis]
5 Hirayama Y, Sato M, Watanabe K. Advancing the Biosynthetic and Chemical Understanding of the Carcinogenic Risk Factor Colibactin and Its Producers. Biochemistry 2022. [PMID: 35723977 DOI: 10.1021/acs.biochem.2c00229] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345